Report Highlights
-
Total worldwide sales of plant-derived drugs in 2002 are estimated at $13.7 billion.
-
Sales are projected to increase at an average annual growth rate (AAGR) of 6.4% through 2007.
-
The U.S. accounts for 50% of the global plant-derived drug market.
-
The U.S. market will grow faster than foreign markets as a whole, at an AAGR of 7.5% per year vs. 5.3%.
INTRODUCTION
As late as the 1930s, approximately 90% of the medicines prescribed or sold overthe- counter were still of herbal origin. Today, an estimated one-quarter of the prescription drugs sold in the United States, Canada and Europe contain active ingredients derived from plants. Even so, global over-the-counter sales of plant-derived drugs are estimated at $40 billion per year, and there is an ongoing revival of interest in plant-derived drugs.
Nobody knows exactly how many plants are used medicinally worldwide, but only an estimated 5% to 15% of the approximately 250,000 higher plants have been investigated for bioactive compounds. Currently, pharmaceutical companies and researchers are looking for new plant-derived drugs, spending millions on screening various plants for active constituents. They also are developing new uses for known herbal remedies and conducting experiments with blends of different herbals.
Nearly five years have passed since BCC published its landmark study of “Plant-Derived Drugs: Products, Technologies and Applications.” This updated version focuses on the global market for plant-derived drugs in light of the most recent available information. In addition to looking at future and current markets for a wide variety of new, reformulated and established products, the study analyzes technological, environmental, legal/regulatory and socioeconomic developments that may influence the market for plant-derived drugs. It, therefore, will be invaluable to presidents, and strategic planners and marketers in all companies comprising the pharmaceutical industry.
SCOPE OF STUDY
This BCC study:
- Provides an analysis of the industry and markets by region, technology, category of drug and medical application
- Analyzes the current and future volume and value of classified plant-derived drugs through 2007
- Evaluates market drivers, as well as technological, environmental, legal/regulatory and socioeconomic factors
- Forecasts the market for plant-derived drugs in the clinical testing or approval stages
- Identifies leading manufacturers along with the firms that may become important players.
ANALYST CREDENTIALS
The author of this report, Andrew McWilliams, is a partner in the Boston-based international technology and marketing consulting firm of 43rd Parallel LLC. He has over 25 years experience in international market assessments and strategy consulting for clients in the technology sector, including biotechnology.
Related Reports
Recent Reports
Companion Diagnostics: Technologies and Markets
The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More